Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesVeradigm Inc.

Veradigm Inc.

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
4.9 USD -0.03 ( 0.61%)
Last update at 2026-11-05T14:30:00Z
VOLUME
1500
Market Cap
941.85M
P/E
10.17

Momentum Score

…

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.78
Low
4.90
High
52 Week Price Range
5.01
Low
14.09
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
4.93
Dividend Yield
-
Revenue TTM
1529.00M
Revenue Per Share
13.29
Gross Profit TTM
738.26M
Debt / Equity
0.31
ROE
8.93%
Net Debt
246.20M
ROCE
9.95%
Diluted EPS TTM
0.86

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Type yearly yearly yearly yearly yearly
Date 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Income before tax 161.80M -149.31M -206.50M 13.10M -209.60M
Minority interest 0.00M 0.00M -0.42M -4.53M -1.57M
Net income 134.40M -132.62M -182.60M 363.70M -196.50M
Selling general administrative 313.81M 389.94M 419.77M 450.97M 486.27M
Gross profit 619.60M 565.70M 713.60M 724.60M 782.10M
Reconciled depreciation 176.14M 212.99M 229.64M 192.35M 218.54M
Ebit 186.80M -38.66M -126.10M -21.10M 41.90M
Ebitda 362.90M 174.33M 103.50M 171.20M 261.70M
Depreciation and amortization 176.10M 212.99M 229.60M 192.30M 219.80M
Non operating income net other 97.79M 17.25M -138.24M 172.59M 1.23M
Operating income 186.80M -38.66M -126.10M -21.10M 41.90M
Other operating expenses 1414.00M 1558.61M 1759.60M 1771.40M 1764.40M
Interest expense 13.20M 34.10M 43.20M 50.90M 87.50M
Tax provision 27.85M -16.69M -23.91M 0.47M -50.77M
Interest income 1.10M - 42.51M 50.66M 36.72M
Net interest income -13.17M -34.10M -43.17M -50.91M -87.48M
Extraordinary items - - 2.97M 346.54M -28.85M
Non recurring - - 25.70M 71.63M -
Income tax expense 27.90M -16.69M -23.90M 0.40M -50.70M
Total revenue 1503.00M 1502.70M 1771.70M 1750.00M 1806.30M
Total operating expenses 530.60M 621.61M 701.50M 746.00M 740.20M
Cost of revenue 883.40M 937.00M 1058.10M 1025.40M 1024.20M
Total other income expense net -25.00M -110.65M -80.40M 34.20M -251.50M
Discontinued operations 0.46M 833.03M 833.00M 395.14M 4.68M
Net income from continuing ops 133.97M -132.62M -182.60M 12.67M -158.85M
Net income applicable to common shares 134.44M 700.41M -182.18M 363.74M -196.46M
Preferred stock and other adjustments - - - 48.59M 43.85M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets - 2425.20M 2917.62M 3205.70M 3181.50M
Intangible assets - 408.00M 479.80M 618.00M 640.80M
Other current assets - 2.30M 3.32M 1.95M 153.01M
Total liab - 1017.10M 1251.38M 1920.50M 1601.10M
Total stockholder equity - 1408.10M 1666.24M 1285.20M 1551.10M
Deferred long term liab - 16.62M 18.19M 21.04M 58.47M
Other current liab - 184.70M 541.84M 339.30M 236.60M
Common stock - 2.77M 2.75M 2.73M 2.71M
Capital stock - 2.77M 2.75M 2.73M 2.71M
Retained earnings - 767.56M 633.12M -49.34M 132.84M
Other liab - 55.10M 55.50M 63.65M 155.79M
Good will - 974.50M 974.73M 1362.00M 1373.70M
Other assets - 164.60M 430.90M 154.22M 149.08M
Cash - 188.30M 531.10M 129.60M 174.20M
Total current liabilities - 547.10M 934.78M 1210.70M 797.70M
Current deferred revenue - 325.90M 334.76M 379.80M 466.80M
Net debt - 246.20M -247.79M 904.20M 495.20M
Short term debt - 19.60M 22.26M 387.60M 21.10M
Short long term debt - - - 364.46M 20.06M
Short long term debt total - 434.50M 283.31M 1033.80M 669.40M
Other stockholder equity - 640.54M 1032.22M 1336.20M 1420.94M
Property plant equipment - 47.90M 72.16M 88.34M 121.91M
Total current assets - 761.30M 1153.22M 841.30M 859.00M
Long term investments - 61.55M 35.80M 43.81M 37.04M
Net tangible assets - 25.63M 211.71M -694.90M -463.37M
Net receivables - 451.90M 479.49M 555.80M 531.70M
Long term debt - 350.06M 167.59M 551.00M 647.54M
Inventory - 118.80M 139.31M 153.95M -
Accounts payable - 16.90M 35.91M 104.00M 73.20M
Noncontrolling interest in consolidated entity - - - - 29.31M
Accumulated other comprehensive income - -2.77M -1.84M -4.39M -5.39M
Common stock total equity - 2.77M 2.75M 2.73M 2.71M
Retained earnings total equity - 767.56M 633.12M -49.34M 132.84M
Treasury stock - -1321.81M -870.56M -571.16M -460.54M
Non currrent assets other - 96.45M 99.50M 148.59M 144.06M
Deferred long term asset charges - - - 5.70M 5.04M
Non current assets total - 1663.90M 1764.40M 2364.40M 2322.50M
Capital lease obligations - 84.42M 115.73M 118.30M 0.77M
Long term debt total - 350.06M 167.59M 551.00M 648.31M
Breakdown 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Type yearly yearly yearly yearly yearly
Date 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Investments -2.42M 17.87M -7.19M -16.93M -5.61M
Change to liabilities -22.59M -15.22M 128.99M 46.86M 149.21M
Total cashflows from investing activities -12.18M 1615.19M -161.06M 248.01M -412.97M
Net borrowings 175.00M -764.49M 271.80M -283.46M 219.75M
Total cash from financing activities -258.90M -1109.76M 67.30M -293.00M 198.60M
Change to operating activities -23.50M -152.30M 61.47M 10.20M 60.04M
Net income 133.90M 700.41M -182.60M 407.80M -154.20M
Change in cash -347.00M 399.93M -47.30M 22.30M 65.90M
Begin period cash flow 537.50M 137.54M 184.80M 162.50M 96.60M
End period cash flow 190.50M 537.47M 137.50M 184.80M 162.50M
Total cash from operating activities -75.40M -106.72M 46.30M 67.90M 279.40M
Issuance of capital stock - 0.00M 0.00M 1.28M -
Depreciation 176.10M 212.99M 229.60M 192.30M 218.50M
Other cashflows from investing activities -4.46M 1614.34M -137.26M 296.26M -360.99M
Dividends paid - - - -580.20M 374.65M
Change to inventory 5.00M -198.58M 93.90M -3.26M 33.00M
Change to account receivables -5.00M 35.16M -13.27M -109.13M -99.43M
Sale purchase of stock -417.50M -334.86M -111.50M -138.90M -12.10M
Other cashflows from financing activities 233.60M 892.47M 196.00M 1139.11M 738.70M
Change to netincome -369.97M -109.81M 6.74M -77.04M 151.46M
Capital expenditures 78.60M 105.02M 130.50M 144.60M 185.30M
Change receivables -5.00M 35.16M -13.27M -109.13M -99.43M
Cash flows other operating 145.99M -76.50M -100.71M 14.86M 13.82M
Exchange rate changes - - - - 0.86M
Cash and cash equivalents changes -346.47M 398.71M -47.46M 22.92M 65.89M
Change in working capital -23.50M -152.25M -18.40M -60.10M 63.60M
Stock based compensation 35.20M 34.04M 39.00M 34.60M 38.80M
Other non cash items -395.00M -898.62M 16.67M -510.84M 168.49M
Free cash flow -154.00M -211.73M -84.20M -76.70M 94.10M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MDRX
Veradigm Inc.		 -0.03
0.61%		 4.90 10.17 15.17 0.54 0.70 0.36 1.85
VEEV
Veeva Systems Inc Class A		 -6.37
2.05%		 303.73 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited		 -
-%		 144.00 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock		 5.62
7.98%		 76.05 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc		 -0.20
3.40%		 5.69 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Veradigm Inc.

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

222 Merchandise Mart Plaza, Chicago, IL, United States, 60654

800 334 8534

https://veradigm.com

8000

Name Title Year Born
Mr. Richard J. Poulton CEO & Director 1965
Ms. Tejal Vakharia Sr. VP of Marketing & Gov. Affairs, Gen. Counsel and Chief Compliance Counsel 1973
Mr. Thomas J. Langan Pres & CCO 1966
Ms. Leah Jones Chief Financial Officer 1972
Mr. Joseph R. Rostock Sr. VP of Devel. & CTO 1963
Jenny Gelinas VP of Investor Relations NA
Mr. Richard Elmore Sr. VP of Corp. Devel. & Strategy NA
Ms. Rebecca Whaley VP of Marketing NA
Ms. Lisa Hammond C.P.C. Sr. VP & Chief HR Officer 1972
Mr. Paul Lewis Sr. VP of Sales & Services and Acting Gen. Mang. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…